Literature DB >> 28375518

Generation and Validation of the iKp1289 Metabolic Model for Klebsiella pneumoniae KPPR1.

Christopher S Henry1, Ella Rotman2, Wyndham W Lathem2, Keith E J Tyo3, Alan R Hauser2,4, Mark J Mandel2.   

Abstract

Klebsiella pneumoniae has a reputation for causing a wide range of infectious conditions, with numerous highly virulent and antibiotic-resistant strains. Metabolic models have the potential to provide insights into the growth behavior, nutrient requirements, essential genes, and candidate drug targets in these strains. Here we develop a metabolic model for KPPR1, a highly virulent strain of K. pneumoniae. We apply a combination of Biolog phenotype data and fitness data to validate and refine our KPPR1 model. The final model displays a predictive accuracy of 75% in identifying potential carbon and nitrogen sources for K. pneumoniae and of 99% in predicting nonessential genes in rich media. We demonstrate how this model is useful in studying the differences in the metabolic capabilities of the low-virulence MGH 78578 strain and the highly virulent KPPR1 strain. For example, we demonstrate that these strains differ in carbohydrate metabolism, including the ability to metabolize dulcitol as a primary carbon source. Our model makes numerous other predictions for follow-up verification and analysis. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Biolog; Klebsiella pneumoniae KPPR1; bacteria; flux balance analysis; gap filling; metabolic model; resistance; transposon insertion sequencing

Mesh:

Substances:

Year:  2017        PMID: 28375518      PMCID: PMC5790149          DOI: 10.1093/infdis/jiw465

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  "Nightmare" bacteria on the rise in US hospitals, long-term care facilities.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2013-04-17       Impact factor: 56.272

2.  High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

Authors:  Doo Ryeon Chung; Jae-Hoon Song; So Hyun Kim; Visanu Thamlikitkul; Shao-Guang Huang; Hui Wang; Thomas Man-Kit So; Rohani M D Yasin; Po-Ren Hsueh; Celia C Carlos; Li Yang Hsu; Latre Buntaran; M K Lalitha; Min Ja Kim; Jun Yong Choi; Sang Il Kim; Kwan Soo Ko; Cheol-In Kang; Kyong Ran Peck
Journal:  Am J Respir Crit Care Med       Date:  2011-09-15       Impact factor: 21.405

3.  Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing.

Authors:  Yanjia J Zhang; Manchi C Reddy; Thomas R Ioerger; Alissa C Rothchild; Veronique Dartois; Brian M Schuster; Andrej Trauner; Deeann Wallis; Stacy Galaviz; Curtis Huttenhower; James C Sacchettini; Samuel M Behar; Eric J Rubin
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

4.  Multidrug resistance in Klebsiella pneumoniae MGH78578 and cloning of genes responsible for the resistance.

Authors:  Wakano Ogawa; Dai-Wei Li; Ping Yu; Anowara Begum; Tohru Mizushima; Teruo Kuroda; Tomofusa Tsuchiya
Journal:  Biol Pharm Bull       Date:  2005-08       Impact factor: 2.233

5.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

6.  Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

Authors:  Ralf Rene Reinert; Donald E Low; Flávia Rossi; Xiaojiang Zhang; Chand Wattal; Michael J Dowzicky
Journal:  J Antimicrob Chemother       Date:  2007-09-13       Impact factor: 5.790

7.  Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding region.

Authors:  Sameer P Kawatkar; Thomas A Keating; Nelson B Olivier; John N Breen; Oluyinka M Green; Satenig Y Guler; Martin F Hentemann; James T Loch; Andrew R McKenzie; Joseph V Newman; Linda G Otterson; Gabriel Martínez-Botella
Journal:  J Med Chem       Date:  2014-06-03       Impact factor: 7.446

8.  The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes.

Authors:  Ross Overbeek; Tadhg Begley; Ralph M Butler; Jomuna V Choudhuri; Han-Yu Chuang; Matthew Cohoon; Valérie de Crécy-Lagard; Naryttza Diaz; Terry Disz; Robert Edwards; Michael Fonstein; Ed D Frank; Svetlana Gerdes; Elizabeth M Glass; Alexander Goesmann; Andrew Hanson; Dirk Iwata-Reuyl; Roy Jensen; Neema Jamshidi; Lutz Krause; Michael Kubal; Niels Larsen; Burkhard Linke; Alice C McHardy; Folker Meyer; Heiko Neuweger; Gary Olsen; Robert Olson; Andrei Osterman; Vasiliy Portnoy; Gordon D Pusch; Dmitry A Rodionov; Christian Rückert; Jason Steiner; Rick Stevens; Ines Thiele; Olga Vassieva; Yuzhen Ye; Olga Zagnitko; Veronika Vonstein
Journal:  Nucleic Acids Res       Date:  2005-10-07       Impact factor: 16.971

9.  Non-traditional antibacterial screening approaches for the identification of novel inhibitors of the glyoxylate shunt in gram-negative pathogens.

Authors:  Kelly C Fahnoe; Mark E Flanagan; Glenn Gibson; Veerabahu Shanmugasundaram; Ye Che; Andrew P Tomaras
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

10.  Vital signs: carbapenem-resistant Enterobacteriaceae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-08       Impact factor: 17.586

View more
  8 in total

1.  Stenotrophomonas maltophilia Encodes a VirB/VirD4 Type IV Secretion System That Modulates Apoptosis in Human Cells and Promotes Competition against Heterologous Bacteria, Including Pseudomonas aeruginosa.

Authors:  Megan Y Nas; Richard C White; Ashley L DuMont; Alberto E Lopez; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

Review 2.  Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: a review.

Authors:  Wan Yean Chung; Yan Zhu; Mohd Hafidz Mahamad Maifiah; Naveen Kumar Hawala Shivashekaregowda; Eng Hwa Wong; Nusaibah Abdul Rahim
Journal:  J Antibiot (Tokyo)       Date:  2020-09-08       Impact factor: 2.649

3.  Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.

Authors:  Danielle Ahn; Alice Prince
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

4.  Application of the Metabolic Modeling Pipeline in KBase to Categorize Reactions, Predict Essential Genes, and Predict Pathways in an Isolate Genome.

Authors:  Benjamin H Allen; Nidhi Gupta; Janaka N Edirisinghe; José P Faria; Christopher S Henry
Journal:  Methods Mol Biol       Date:  2022

5.  Pulmonary Surfactant Promotes Virulence Gene Expression and Biofilm Formation in Klebsiella pneumoniae.

Authors:  Graham G Willsey; Sebastian Ventrone; Kristin C Schutz; Aaron M Wallace; John W Ribis; Benjamin T Suratt; Matthew J Wargo
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

6.  The Klebsiella pneumoniae citrate synthase gene, gltA, influences site specific fitness during infection.

Authors:  Jay Vornhagen; Yuang Sun; Paul Breen; Valerie Forsyth; Lili Zhao; Harry L T Mobley; Michael A Bachman
Journal:  PLoS Pathog       Date:  2019-08-26       Impact factor: 6.823

7.  Network-Based Metabolism-Centered Screening of Potential Drug Targets in Klebsiella pneumoniae at Genome Scale.

Authors:  Müberra Fatma Cesur; Bushra Siraj; Reaz Uddin; Saliha Durmuş; Tunahan Çakır
Journal:  Front Cell Infect Microbiol       Date:  2020-01-14       Impact factor: 5.293

8.  A curated collection of Klebsiella metabolic models reveals variable substrate usage and gene essentiality.

Authors:  Jane Hawkey; Ben Vezina; Jonathan M Monk; Louise M Judd; Taylor Harshegyi; Sebastián López-Fernández; Carla Rodrigues; Sylvain Brisse; Kathryn E Holt; Kelly L Wyres
Journal:  Genome Res       Date:  2022-03-11       Impact factor: 9.438

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.